Determining the structural role of an oxidoreductase involved in the biosyntesis of gentamicin X2 from Micromonospora echinospora
Antibiotics represent a class of natural products that generally inhibit the growth of bacteria or fungi by blocking processes which are crucial to the microorganism’s survival. Amongst these natural products are the aminoglycosides, a class of antibiotics which is characterized by having a nucleus derived from an aminocyclitol attached to various amino or deoxy sugars. Gentamicin is one of the most functionalized aminoglycosides due to extensive methylations and aminations in its sugar groups. This antibiotic is the fermentation product of the bacteria Micromonospora echinospora and it’s mechanism of action occurs by binding to the 30S portion of the bacterial ribosome, thereby inhibiting protein synthesis. The biosynthesis of this natural product is poorly understood and amongst the enzymes involved in the production of one of it’s unusual sugars, the NAD-dependent oxidoreductase GenD2 was identified. This enzyme acts at the C3” position of gentamicin A2 to produce gentamicin X2. GenD2 catalyzes the reduction of a hydroxyl producing a keto group at this position, which is further aminated. Aiming to understand the catalytic mechanism of this enzyme, we intend to structurally characterize GenD2. Thus, genD2 was sub-cloned in pET - 28a(+) and over-expressed in E coli BL21 (DE3) cells with N-terminal His6 tag. The recombinant protein was purified by nickel-affinity and gel filtration chromatography and the purified protein was verified on 12% SDS-PAGE. Crystallization assays were carried out using an Oryx4 Douglas robot and the sitting drop vapor-diffusion method. We have successfully expressed GenD2 and managed to obtain pure and soluble sample for crystallization assays. GenD2 crystals were obtained in a specific condition composed of 0.2 M ammonium acetate, 0,1 M Tris hydrochloride pH 8,5, 30% 2-propanol. The X-ray diffraction data collection was performed at PETRA III (DESy), Germany. The data set was processed using the program XDS and the reflection file was scaled by AIMLESS from the CCP4 program package. The GenD2 crystal, which diffracted up to 2.2 Å resolution, belongs to the spatial group P 2 21 21 and the data presents a completeness of 99,9%. The GenD2 structure is being solved by molecular replacement using the homologue model Dhaf_2064 (PDB entry 3dB2), an oxidoreductase of Desulfitobacterium hafniense that shows 27% identity with 70% coverage. Despite the low homology between these two proteins, it was possible to obtain the phase for structure determination. The information obtained in this work might contribute to the understanding of the intricate biosynthetic pathway of gentamicin, as well as generate useful information for the production of new and less toxic aminoglycosides derivatives through biotechnological tools.